Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 33% ± 8% | |
B cell | 4 studies | 26% ± 7% | |
GABAergic neuron | 4 studies | 39% ± 16% | |
plasmablast | 3 studies | 36% ± 12% | |
conventional dendritic cell | 3 studies | 35% ± 11% | |
transit amplifying cell | 3 studies | 26% ± 7% | |
glutamatergic neuron | 3 studies | 49% ± 14% | |
dendritic cell | 3 studies | 28% ± 7% | |
granulocyte monocyte progenitor cell | 3 studies | 23% ± 5% | |
hematopoietic precursor cell | 3 studies | 23% ± 2% | |
interneuron | 3 studies | 34% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1773.67 | 2641 / 2642 | 99% | 12.96 | 697 / 705 |
pancreas | 98% | 720.42 | 323 / 328 | 99% | 15.66 | 176 / 178 |
kidney | 100% | 699.94 | 89 / 89 | 93% | 10.93 | 834 / 901 |
stomach | 92% | 978.13 | 329 / 359 | 100% | 38.39 | 286 / 286 |
skin | 100% | 1162.89 | 1807 / 1809 | 92% | 10.52 | 432 / 472 |
prostate | 94% | 416.53 | 230 / 245 | 96% | 12.14 | 483 / 502 |
breast | 90% | 422.34 | 415 / 459 | 99% | 21.35 | 1111 / 1118 |
thymus | 96% | 533.19 | 626 / 653 | 93% | 8.95 | 560 / 605 |
lung | 88% | 446.27 | 508 / 578 | 100% | 20.96 | 1151 / 1155 |
liver | 100% | 745.26 | 226 / 226 | 86% | 10.14 | 351 / 406 |
intestine | 81% | 1311.98 | 785 / 966 | 100% | 40.04 | 527 / 527 |
uterus | 84% | 284.08 | 142 / 170 | 97% | 22.36 | 447 / 459 |
esophagus | 77% | 745.59 | 1119 / 1445 | 100% | 31.51 | 183 / 183 |
bladder | 76% | 287.90 | 16 / 21 | 97% | 21.64 | 490 / 504 |
adrenal gland | 92% | 403.47 | 238 / 258 | 79% | 7.54 | 182 / 230 |
ovary | 51% | 159.11 | 92 / 180 | 99% | 16.12 | 427 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 38.59 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.06 | 1 / 1 |
spleen | 100% | 1099.84 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 89% | 373.59 | 1070 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 81% | 324.13 | 1079 / 1335 | 0% | 0 | 0 / 0 |
heart | 72% | 253.84 | 619 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 69% | 1566.56 | 645 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 51% | 3.58 | 41 / 80 |
muscle | 18% | 44.93 | 142 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | BRI3BP |
Protein name | BRI3-binding protein (I3-binding protein) (Cervical cancer 1 proto-oncogene-binding protein KG19) (HCCRBP-1) BRI3 binding protein |
Synonyms | KG19 |
Description | FUNCTION: Involved in tumorigenesis and may function by stabilizing p53/TP53. . |
Accessions | Q8WY22 ENST00000671775.2 A0A5F9ZHY7 ENST00000672415.1 ENST00000341446.9 |